EUVIMEDEUVIMED entdecken
Editorial

Radioligand Therapy of the Prostate – the Sky Is the Limit?

Wolfgang P Fendler, Ken Herrmann

European Urology Focus · 2026-10 · 12 (5) · 823-824

DOI: 10.1016/j.euf.2026.08.003 ↗

Kurz gefasst

Editorial in der Zeitschrift European Urology Focus, 2026-10. Verfasst von Wolfgang P Fendler und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), partner site E…. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), partner site Essen, a partnership between German Cancer Research Center (DKFZ) and U…

Zitieren

APA

Fendler, W. P., & Herrmann, K. (2026). Radioligand Therapy of the Prostate – the Sky Is the Limit?. European Urology Focus, 12(5), 823-824. https://doi.org/10.1016/j.euf.2026.08.003

Vancouver

Fendler WP, Herrmann K. Radioligand Therapy of the Prostate – the Sky Is the Limit?. European Urology Focus. 2026;12(5):823-824. doi:10.1016/j.euf.2026.08.003

BibTeX
@article{Fendler2026,
  author = {Fendler, Wolfgang P and Herrmann, Ken},
  title = {Radioligand Therapy of the Prostate – the Sky Is the Limit?},
  journal = {European Urology Focus},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {823--824},
  doi = {10.1016/j.euf.2026.08.003}
}
Kostenlos starten →